133 related articles for article (PubMed ID: 34954873)
1. Biophysical investigation of the dual binding surfaces of human transcription factors FOXO4 and p53.
Kim J; Ahn D; Park CJ
FEBS J; 2022 Jun; 289(11):3163-3182. PubMed ID: 34954873
[TBL] [Abstract][Full Text] [Related]
2. FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.
Mandal R; Kohoutova K; Petrvalska O; Horvath M; Srb P; Veverka V; Obsilova V; Obsil T
Protein Sci; 2022 May; 31(5):e4287. PubMed ID: 35481640
[TBL] [Abstract][Full Text] [Related]
3. FOXO4 Transactivation Domain Interaction with Forkhead DNA Binding Domain and Effect on Selective DNA Recognition for Transcription Initiation.
Kim J; Ahn D; Park CJ
J Mol Biol; 2021 Feb; 433(4):166808. PubMed ID: 33450250
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics procedure for investigating senolytic (anti-aging) agents: A digital signal processing technique.
Nwankwo N; Okafor I
Aging Med (Milton); 2023 Dec; 6(4):338-346. PubMed ID: 38239718
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53.
Wang F; Marshall CB; Yamamoto K; Li GY; Plevin MJ; You H; Mak TW; Ikura M
J Mol Biol; 2008 Dec; 384(3):590-603. PubMed ID: 18824006
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cellular senescence via the FOXO4-p53 axis.
Bourgeois B; Madl T
FEBS Lett; 2018 Jun; 592(12):2083-2097. PubMed ID: 29683489
[TBL] [Abstract][Full Text] [Related]
7. Multiple regulatory intrinsically disordered motifs control FOXO4 transcription factor binding and function.
Bourgeois B; Gui T; Hoogeboom D; Hocking HG; Richter G; Spreitzer E; Viertler M; Richter K; Madl T; Burgering BMT
Cell Rep; 2021 Jul; 36(4):109446. PubMed ID: 34320339
[TBL] [Abstract][Full Text] [Related]
8. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
9. Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding.
Boura E; Silhan J; Herman P; Vecer J; Sulc M; Teisinger J; Obsilova V; Obsil T
J Biol Chem; 2007 Mar; 282(11):8265-75. PubMed ID: 17244620
[TBL] [Abstract][Full Text] [Related]
10. Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
Le HH; Cinaroglu SS; Manalo EC; Ors A; Gomes MM; Duan Sahbaz B; Bonic K; Origel Marmolejo CA; Quentel A; Plaut JS; Kawashima TE; Ozdemir ES; Malhotra SV; Ahiska Y; Sezerman U; Bayram Akcapinar G; Saldivar JC; Timucin E; Fischer JM
EBioMedicine; 2021 Nov; 73():103646. PubMed ID: 34689087
[TBL] [Abstract][Full Text] [Related]
11. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
[TBL] [Abstract][Full Text] [Related]
12. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice.
Zhang C; Xie Y; Chen H; Lv L; Yao J; Zhang M; Xia K; Feng X; Li Y; Liang X; Sun X; Deng C; Liu G
Aging (Albany NY); 2020 Jan; 12(2):1272-1284. PubMed ID: 31959736
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3 protein masks the DNA binding interface of forkhead transcription factor FOXO4.
Silhan J; Vacha P; Strnadova P; Vecer J; Herman P; Sulc M; Teisinger J; Obsilova V; Obsil T
J Biol Chem; 2009 Jul; 284(29):19349-60. PubMed ID: 19416966
[TBL] [Abstract][Full Text] [Related]
14. Detailed kinetic analysis of the interaction between the FOXO4-DNA-binding domain and DNA.
Vacha P; Zuskova I; Bumba L; Herman P; Vecer J; Obsilova V; Obsil T
Biophys Chem; 2013 Dec; 184():68-78. PubMed ID: 24121535
[TBL] [Abstract][Full Text] [Related]
15. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.
Baar MP; Brandt RMC; Putavet DA; Klein JDD; Derks KWJ; Bourgeois BRM; Stryeck S; Rijksen Y; van Willigenburg H; Feijtel DA; van der Pluijm I; Essers J; van Cappellen WA; van IJcken WF; Houtsmuller AB; Pothof J; de Bruin RWF; Madl T; Hoeijmakers JHJ; Campisi J; de Keizer PLJ
Cell; 2017 Mar; 169(1):132-147.e16. PubMed ID: 28340339
[TBL] [Abstract][Full Text] [Related]
16. Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways.
Ha JH; Shin JS; Yoon MK; Lee MS; He F; Bae KH; Yoon HS; Lee CK; Park SG; Muto Y; Chi SW
J Biol Chem; 2013 Mar; 288(10):7387-98. PubMed ID: 23316052
[TBL] [Abstract][Full Text] [Related]
17. Current perspective on the regulation of FOXO4 and its role in disease progression.
Liu W; Li Y; Luo B
Cell Mol Life Sci; 2020 Feb; 77(4):651-663. PubMed ID: 31529218
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an Hsp90-Independent Interaction between Co-Chaperone p23 and Transcription Factor p53.
Wu H; Hyun J; Martinez-Yamout MA; Park SJ; Dyson HJ
Biochemistry; 2018 Feb; 57(6):935-944. PubMed ID: 29334217
[TBL] [Abstract][Full Text] [Related]
19. Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.
He F; Borcherds W; Song T; Wei X; Das M; Chen L; Daughdrill GW; Chen J
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8859-8868. PubMed ID: 30988205
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interplay between promoter recognition and CBP/p300 coactivator recruitment by FOXO3a.
Wang F; Marshall CB; Li GY; Yamamoto K; Mak TW; Ikura M
ACS Chem Biol; 2009 Dec; 4(12):1017-27. PubMed ID: 19821614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
